Structure of pathological TDP-43 filaments from ALS with FTLD

被引:0
|
作者
Diana Arseni
Masato Hasegawa
Alexey G. Murzin
Fuyuki Kametani
Makoto Arai
Mari Yoshida
Benjamin Ryskeldi-Falcon
机构
[1] MRC Laboratory of Molecular Biology,Department of Brain and Neurosciences
[2] Tokyo Metropolitan Institute of Medical Science,Department of Psychiatry and Behavioural Sciences
[3] Tokyo Metropolitan Institute of Medical Science,Institute for Medical Science of Aging
[4] Aichi Medical University,undefined
来源
Nature | 2022年 / 601卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD)1,2. It is also common in other diseases, including Alzheimer’s and Parkinson’s. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282–360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro3,4. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.
引用
收藏
页码:139 / 143
页数:4
相关论文
共 50 条
  • [31] Functional recovery in new mouse models of ALS/FTLD after clearance of TDP-43 pathology
    Walker, A.
    Spiller, K.
    Ge, G.
    Zheng, A.
    Xu, Y.
    Zhou, M.
    Tripathy, K.
    Kwong, L.
    Trojanowski, J.
    Lee, V.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 208 - 209
  • [32] Abnormal phosphorylation of ser409/410 of TDP-43 in FTLD-U and ALS
    Inukai, Yuki
    Nonaka, Takashi
    Arai, Tetsuaki
    Yoshida, Mari
    Hashizume, Yoshio
    Beach, Thomas G.
    Buratti, Emanuele
    Baralle, Francisco E.
    Akiyama, Haruhiko
    Hisanaga, Shin-ichi
    Hasegawa, Masato
    FEBS LETTERS, 2008, 582 (19) : 2899 - 2904
  • [33] Transgenic Rat Overexpressing TDP-43, an Animal Model to study FTLD-U and ALS
    Koza, Paulina
    Klejman, Agata
    Gorkiewicz, Tomasz
    Knapska, Ewelina
    Kaczmarek, Leszek
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 52 - 53
  • [34] Metals in ALS TDP-43 Pathology
    Koski, Lassi
    Ronnevi, Cecilia
    Berntsson, Elina
    Warmlander, Sebastian K. T. S.
    Roos, Per M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [35] TDP-43 and Cytoskeletal Proteins in ALS
    Moritz Oberstadt
    Joseph Claßen
    Thomas Arendt
    Max Holzer
    Molecular Neurobiology, 2018, 55 : 3143 - 3151
  • [36] TDP-43 and Cytoskeletal Proteins in ALS
    Oberstadt, Moritz
    Classen, Joseph
    Arendt, Thomas
    Holzer, Max
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 3143 - 3151
  • [37] Mechanisms of Disease in FTLD - TDP-43 loss of function
    Cairns, Nigel J.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 3 - 4
  • [38] TDP-43 in the spectrum of MND-FTLD pathologies
    Heyburn, Lanier
    Moussa, Charbel E. -H.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2017, 83 : 46 - 54
  • [39] TDP-43 Puts the STING in ALS
    Lee, John D.
    Woodruff, Trent M.
    TRENDS IN NEUROSCIENCES, 2021, 44 (02) : 81 - 82
  • [40] Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells
    Nonaka, Takashi
    Arai, Tetsuaki
    Buratti, Emanuele
    Baralle, Francisco E.
    Akiyama, Haruhiko
    Hasegawa, Masato
    FEBS LETTERS, 2009, 583 (02): : 394 - 400